Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Glioblastoma 16Medulloblastoma 5Glioma 5Brain Neoplasms 5Neoplasms 3Recurrence 2Oligodendroglioma 2Central Nervous System Neoplasms 2Sarcoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Gliosarcoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Breast Neoplasms 1Bone Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 3regorafenib 2Proton Therapy 2Methods 2Gemcitabine 2Doxorubicin 2tocilizumab 1poly ICLC 1pembrolizumab 1liposomal doxorubicin 1fludarabine 1flt3 ligand protein 1endostar protein 1alectinib 1aldesleukin 1Weight-Bearing 1Transcranial Direct Current Stimulation 1Taxes 1Surveys and Questionnaires 1Standard of Care 1Restraint, Physical 1Range of Motion, Articular 1Radiotherapy 1Radiosurgery 1Radiation 1Quality of Life 1Psychology, Positive 1Platinum 1Paclitaxel 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × Lomustine × 1 year × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡